Resource Logo
AIDS Treatment Data Network

(ATDN) Treatment Briefs: Lobucavir for CMV


Treatment Review No. 23 - December 1996

A new drug called lobucavir is being studied for the treatment of newly diagnosed CMV retinitis. CMV retinitis is an infection caused by a herpesvirus that people with low T4 cells can get. If untreated, the infection leads to blindness. Lobucavir is an antiviral drug that is active against many different herpesviruses, as well as HIV. In an early study, lobucavir reduced the amount of HIV in the blood by over 90%. Lobucavir is a pill that is taken 4 times a day. Call the Network if you'd like a referral to the study site.


Copyright © 1996 -AIDS Treatment Data Network, Publisher. All rights reserved to AIDS Treatment Data Network. Reproduction of this article (other than one copy for personal reference) must be cleared through the AIDS Treatment Data Network. Email AIDS Treatment Data Network

Information in this article was accurate in December 1, 1996. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.